LHH1

General Information


DRACP ID  DRACP02842

Peptide Name   LHH1

Sequence  AFALIAGALYRIFHRR

Sequence Length  16

UniProt ID  Q036I7 

PubChem CID  Not available

Origin  Lactobacillus casei HZ1

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis Induce apoptosis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HCT 116 Colon carcinoma Carcinoma IC50=40.83 μM MTT assay 24 h 1
C666-1 Nasopharyngeal carcinoma Carcinoma IC50=18.27 μM MTT assay 24 h 1
MGC-803 Gastric mucinous adenocarcinoma Carcinoma IC50=31.55 μM MTT assay 24 h 1

Hemolytic Activity  Goat erythrocytes: HC50=187.2 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02842

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C89H139N27O18

Absent amino acids  CDEKMNPQSTVW

Common amino acids  A

Mass  214300

Pl  12.2

Basic residues  4

Acidic residues  0

Hydrophobic residues  10

Net charge  4

Boman Index  -1574

Hydrophobicity  68.75

Aliphatic Index  122.5

Half Life 
  Mammalian: 2.8 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  99.33

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33175275

Title  LHH1, a novel antimicrobial peptide with anti-cancer cell activity identified from Lactobacillus casei HZ1

Doi 10.1186/s13568-020-01139-8

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_16955

DRACP is developed by Dr.Zheng's team.